Regeneron’s experimental coronavirus treatment has been received emergency use approval from the Food and Drug Administration. The therapy, REGN-COV2, is part of the monoclonal antibodies class of treatments. (CNBC)
Pfizer and BioNTech have requested emergency use approval from the Food and Drug Administration for their COVID-19 vaccine. An advisory committee is set to meet in December to make a decision. (AP News)
Some Americans could receive a COVID-19 vaccine by mid-December, according to U.S. health officials. The vaccine could be distributed to some as soon as 24-hours after receiving FDA approval. (Reuters)
There were more than 195,500 new cases of coronavirus in the U.S. on Friday. The COVID Tracking Project says more than 81,200 are people are currently hospitalized. (CNBC)
The third annual MM+M Holiday Contest is open for submissions. Entries are due by December 7. (MM+M)
